{"Clinical Trial ID": "NCT00382785", "Intervention": ["INTERVENTION 1:", "Moderate group", "A 12-week online support group led by a health professional", "INTERVENTION 2:", "* Not facilitated (peer-led)", "A 12-week online support in a peer-led format"], "Eligibility": ["Inclusion Criteria: Clinical Diagnosis of Breast Cancer", "Women", "At least 21 years", "\u2022 Access to the Internet; Ability to read and write English", "Have completed breast cancer treatment in the past 36 months or have received treatment", "Do not currently belong to an online or face-to-face support group for cancer", "\u2022 Internet access", "- Exclusion criteria:", "Men", "No breast cancer diagnosis", "Under 21 years", "More than 36 months ago, we received treatment for breast cancer.", "No Internet access", "Unable to read and write English"], "Results": ["Performance measures:", "Results of the Personal Resources Questionnaire 85.", "\u00b7 The Personal Resources Questionnaire 85 (PRQ85), Part II, measures perceived social support and consists of 25 elements in a seven-point Likert format that are rated seven (7) strongly agree, to one (1) strongly disagree. Scores range from 25 to 175 with higher scores indicating higher levels of perceived social support.", "Time limit: 16 weeks", "Results 1:", "Title of arm/group: Moderate group", "A 12-week online support group led by a health professional", "Total number of participants analysed: 25", "Average (standard error)", "Unit of measurement: scores on a scale 50.22 (3.23)", "Results 2:", "Title of arm/group: Unfacilitated (peer-led)", "Description of the arm/group: 12-week online support in a peer-led format", "Total number of participants analysed: 26", "Average (standard error)", "Unit of measure: scores on a scale 53.44 (3.08)"], "Adverse Events": ["Undesirable Events 1:", "Total: 0/25 (0.00 per cent)", "Adverse Events 2:", "Total: 0/26 (0.00 per cent)"]}